UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13A-16 OR 15D-16 UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For the month of September 2025
Commission File Number: 001-16601
FRONTLINE PLC
(Translation of registrant's name into English)
8, Kennedy Street, Iris House, Off. 740B, 3106 Limmasol, Cyprus
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Attached hereto as Exhibit 1 is a copy of the press release issued by Frontline plc (the “Company”) on May 27, 2025,
announcing that the Company has granted 362,284 synthetic options to management and employees of the Company.
Attached hereto as Exhibit 2 is a copy of the press release issued by the Company on September 8, 2025 announcing that a director of the Company exercised 44,000 synthetic options in the Company.
Attached hereto as Exhibit 3 is a copy of the press release issued by the Company on September 12, 2025 announcing that the Chief Executive Officer of Frontline Management AS exercised 110,000 synthetic options in
the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
FRONTLINE PLC
(registrant)
|
|
|
|
|
|
|
|
Dated: September 18, 2025
|
|
By:
|
/s/ Inger M. Klemp
|
|
|
|
|
Name: Inger M. Klemp
|
|
|
|
|
Title: Principal Financial Officer
|
|
|
|
|
|
|
|
|
|
|
EXHIBIT 1
FRO – Grant of synthetic options
27.05.2025
Frontline plc (“Frontline” or the “Company”) hereby announces that 362,284 synthetic options have today been granted to management and employees of
the Company. The synthetic options will have a five-year term expiring May 27, 2030, and will vest over a three-year vesting period as follows:
| • |
1/3 of the synthetic options will vest on May 27, 2026
|
| • |
1/3 of the synthetic options will vest on May 27, 2027
|
| • |
1/3 of the synthetic options will vest on May 27, 2028
|
The exercise price of the synthetic options is USD 16.8 being the volume-weighted average price of the share the last 30 days prior to grant. The
exercise price will further be adjusted for any distribution of dividends made before the relevant synthetic options are exercised. The synthetic options granted to the CEO and the CFO are subject to a cap on maximum annual gain equal to two times
the annual base salary at the time of exercise of the synthetic options.
The synthetic options will be settled in cash based on the difference between the market price of the Company’s shares and the exercise price on the
date of exercise.
The synthetic options have been granted according to the rules of the Company’s synthetic option scheme approved by the Board of Directors of the
Company. Please see the attached forms of notification of transactions by primary insiders for the synthetic options.
May 27, 2025
The Board of Directors
Frontline plc
Limassol, Cyprus
Frontline plc
Limassol, Cyprus
This notification has been publicly disclosed in accordance with Article 19 of the Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.
Attachment
| • |
PDMR transactions
|
Notification of transactions by persons discharging
managerial responsibilities and persons closely associated with them
managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
||
|
a)
|
Name
|
Lars H. Barstad
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
CEO of Frontline Management AS
|
|
|
b)
|
Initial notification/ Amendment
|
Initial notification
|
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
||
|
a)
|
Name
|
Frontline plc
|
|
|
b)
|
LEI
|
5493004BCIKYU1YL3H63
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Synthetic options giving a right to cash settlements depending on the development of the company's share price.
ISIN: CY0200352116
|
|
|
b)
|
Nature of the transaction
|
Lars H. Barstad has on May 27th, 2025, been granted 115,509 synthetic options in Frontline plc (the "Company")
approved by the Board of Directors of the Company on May 27th, 2025.
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
NOK 0
|
115,509 synthetic options
|
||
|
d)
|
Aggregated information
— Aggregated volume
— Price
|
115,509 synthetic options
NOK 0 |
|
|
e)
|
Date of the transaction
|
May 27th, 2025
|
|
|
f)
|
Place of transaction
|
Off market
|
|
Notification of transactions by persons discharging
managerial responsibilities and persons closely associated with them
managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
||
|
a)
|
Name
|
Inger M. Klemp
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
CFO of Frontline Management AS
|
|
|
b)
|
Initial notification/ Amendment
|
Initial notification
|
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
||
|
a)
|
Name
|
Frontline plc
|
|
|
b)
|
LEI
|
5493004BCIKYU1YL3H63
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Synthetic options giving a right to cash settlements depending on the development of the company's share price.
ISIN: CY0200352116
|
|
|
b)
|
Nature of the transaction
|
Inger M. Klemp has on May 27th, 2025, been granted 86,632 synthetic options in Frontline plc (the "Company") approved
by the Board of Directors of the Company on May 27th, 2025.
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
NOK 0
|
86,632 synthetic options
|
||
|
d)
|
Aggregated information
— Aggregated volume
— Price
|
86,632 synthetic options
NOK 0 |
|
|
e)
|
Date of the transaction
|
May 27th, 2025
|
|
|
f)
|
Place of transaction
|
Off market
|
|
EXHIBIT 2
FRO – Notification of Trade
08.09.2025
Issuer
Frontline plc
James O'Shaughnessy, Director of Frontline plc (“Frontline” or the “Company”),
has on September 8th, 2025, exercised 44,000 synthetic options in Frontline
under its share option scheme approved by the Board of Directors of the Company
on December 7, 2021.
Please see the attached form for notification and public disclosure of
transaction attached.
This notification has been publicly disclosed in accordance with Article 19 of
the Market Abuse Regulation section 5-12 of the Norwegian Securities Trading
Act.
Attachment
| • |
PDMR transactions
|
Notification of transactions by persons discharging
managerial responsibilities and persons closely associated with them
managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
||
|
a)
|
Name
|
James O'Shaughnessy
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
Director of Frontline plc
|
|
|
b)
|
Initial notification/ Amendment
|
Initial notification
|
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
||
|
a)
|
Name
|
Frontline plc
|
|
|
b)
|
LEI
|
5493004BCIKYU1YL3H63
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||
|
a)
|
Description of the
Financial instrument, type of instrument |
Synthetic options giving a right to cash settlements depending on the development of the company's share price.
|
|
|
Identification code
|
ISIN: CY0200352116
|
||
|
b)
|
Nature of the transaction
|
James O'Shaughnessy has on September 8th, 2025, exercised 44,000 synthetic options in Frontline plc (the "Company") under its share
option scheme approved by the Board of Directors of the Company on December 7, 2021. The exercise price will be NOK 16.75, adjusted from NOK 71 / NOK 76 due to $5.35 dividend paid per share since the options were granted.
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
NOK 227.72
|
44,000 synthetic options
|
||
|
d)
|
Aggregated information
— Aggregated volume
— Price
|
44,000 synthetic options
NOK 227.72 |
|
|
e)
|
Date of the transaction
|
September 8th, 2025
|
|
|
f)
|
Place of transaction
|
Off market
|
|
EXHIBIT 3
FRO – Notification of Trade
12.09.2025
Issuer
Frontline plc
Lars H. Barstad, CEO of Frontline Management AS, has on September 12th, 2025,
exercised 110,000 synthetic options in Frontline plc (“Frontline” or the
“Company”) under its share option scheme approved by the Board of Directors of
the Company on December 7, 2021. After the transaction Mr. Lars H. Barstad holds
405,509 synthetic options in the Company.
Please see the attached form for notification and public disclosure of
transaction attached.
This notification has been publicly disclosed in accordance with Article 19 of
the Market Abuse Regulation section 5-12 of the Norwegian Securities Trading
Act.
Attachment
| • |
PDMR transactions
|
Notification of transactions by persons discharging
managerial responsibilities and persons closely associated with them
managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|||
|
a)
|
Name
|
Lars H. Barstad
|
||
|
2
|
Reason for the notification
|
|||
|
a)
|
Position/status
|
CEO of Frontline Management AS
|
||
|
b)
|
Initial notification/ Amendment
|
Initial notification
|
||
|
3
|
Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
|
|||
|
a)
|
Name
|
Frontline plc
|
||
|
b)
|
LEI
|
5493004BCIKYU1YL3H63
|
||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||
|
a)
|
Description of the
Financial instrument,
type of instrument |
Synthetic options giving a right to cash settlements depending on the development of the company's share price.
|
||
|
Identification code
|
ISIN: CY0200352116
|
|||
|
b)
|
Nature of the transaction
|
Lars H. Barstad has on September 12th, 2025, exercised 110,000 synthetic options in Frontline plc (the "Company") under its
share option scheme approved by the Board of Directors of the Company on December 7, 2021. The exercise price will be about NOK 10.70, adjusted from NOK 71 due to $5.71 dividend paid per share since the options were granted and the dividend
payable on 24.09.2025.
|
||
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
NOK 229.8667
|
110,000 synthetic options
|
|||
|
d)
|
Aggregated information
— Aggregated volume — Price |
110,000 synthetic options
NOK 229.8667 |
||
|
e)
|
Date of the transaction
|
September 12th, 2025
|
||
|
f)
|
Place of transaction
|
Off market
|
||